SEC Form D filing

General Oncology, Inc., 2026-04-23

An SEC Form D private-offering notice from Newton, MA, a $4,805,299 filer-stated offering target in Biotech. Filed 2026-04-23. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

General Oncology, Inc. site↗ Verified via SEC Form D

Biopharmaceutical company developing GO-4, a multi-modal investigational drug for metastatic and BRCA-mutated cancers including pancreatic cancer.

Filed 2026-04-23Filed to raise $4,805,299First money in 2026-04-15Raised so far $4,805,299HQ (as filed) Newton, MASector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified generaloncology.com↗Named in the filing 5 executives & directors
Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source